Cost-Effectiveness of Pre versus Post Liver Transplant Hepatitis C Treatment with Direct-Acting Antivirals

BACKGROUND & AIMS: Oral direct-acting antivirals (DAAs) for hepatitis C virus (HCV) treatment offer new hope to both pre- and post-liver transplant (LT) patients. However, whether to treat HCV patients pre- versus post-LT is not clear, as treatment can improve liver function but could reduce the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Gastroenterol Hepatol
Main Authors: Samur, Sumeyye, Kues, Brian, Ayer, Turgay, Roberts, Mark S., Kanwal, Fasiha, Hur, Chin, Donnell, Drew Michael S., Chung, Raymond T., Chhatwal, Jagpreet
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5733714/
https://ncbi.nlm.nih.gov/pubmed/28634131
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cgh.2017.06.024
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados